Working… Menu

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy (PEDS-PLAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02559778
Recruitment Status : Recruiting
First Posted : September 24, 2015
Last Update Posted : November 18, 2020
Dell, Inc.
Beat NB Cancer Foundation
KC Pharma
Information provided by (Responsible Party):
Giselle SaulnierSholler, Atrium Health

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2027
Estimated Study Completion Date : September 2032